Bruce N. Jacobs
Chief Financial OfficerMr. Bruce N. Jacobs, C.F.A., M.B.A., has been Chief Financial Officer at Kymera Therapeutics, Inc. since July 2019. Mr. Jacobs is a Partner and Portfolio Manager of Consulting Group Capital Markets Funds - Small Capitalization Growth Investments. Mr. Jacobs serves as Portfolio Manager at EQ Advisors Trust - Multimanager Aggressive Equity Portfolio and GPS Funds I - GuideMark Opportunistic Equity Fund and Partner at Harbor Funds - Harbor Small Cap Growth Fund. He serves as a Portfolio Manager at Consulting Group Capital Markets Funds - Large Capitalization Growth Investments. He was a Partner and Portfolio Manager at Westfield Capital Management Company, L.P. from April 2004 to June 2019. From 1996 to 2004, he served as a Director and Senior Equity Analyst at Deutsche Bank Securities. Mr. Jacobs serves as the Chair of the board of directors at Boys & Girls Clubs of Boston. From 1993 to 1994, he served as an Associate at Alex Brown & Sons Ltd. From 1991 to 1993, he served as a Financial Analyst of Healthcare Group at Alex. Brown & Sons Inc. He serves on the Board of Advisors for Life Sciences Cares. Mr. Jacobs is a Chartered Financial Analyst. He has obtained an M.B.A. from the Harvard Business School in 1996 and B.S. from The Wharton School of the University of Pennsylvania in 1991.
Positions
- Company NameKymera Therapeutics, Inc.Stock CodeKYMRPositionChief Financial OfficerColleagues
- NMNello MainolfiCo-Founder, President, CEO & Director
- FJFelix James BakerIndependent Chairman
- BRBrian R. AdamsChief Legal Officer & Corporate Secretary
- JAJared A. GollobAdvisor
- NGNoah GoodmanChief Business Officer
- JWJeffrey W. AlbersIndependent Director
- PEPamela EspositoIndependent Director
- EHElena H. RidloffIndependent Director
